CLGN vs. SGHT, ZJYL, STIM, LNSR, ECOR, PDEX, EDAP, FONR, TELA, and MLSS
Should you be buying CollPlant Biotechnologies stock or one of its competitors? The main competitors of CollPlant Biotechnologies include Sight Sciences (SGHT), Jin Medical International (ZJYL), Neuronetics (STIM), LENSAR (LNSR), electroCore (ECOR), Pro-Dex (PDEX), Edap Tms (EDAP), FONAR (FONR), TELA Bio (TELA), and Milestone Scientific (MLSS). These companies are all part of the "medical equipment" industry.
CollPlant Biotechnologies vs.
Sight Sciences (NASDAQ:SGHT) and CollPlant Biotechnologies (NASDAQ:CLGN) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their dividends, community ranking, profitability, valuation, media sentiment, analyst recommendations, earnings, risk and institutional ownership.
55.5% of Sight Sciences shares are owned by institutional investors. Comparatively, 21.7% of CollPlant Biotechnologies shares are owned by institutional investors. 28.9% of Sight Sciences shares are owned by company insiders. Comparatively, 9.6% of CollPlant Biotechnologies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.
In the previous week, Sight Sciences had 3 more articles in the media than CollPlant Biotechnologies. MarketBeat recorded 3 mentions for Sight Sciences and 0 mentions for CollPlant Biotechnologies. Sight Sciences' average media sentiment score of 0.51 beat CollPlant Biotechnologies' score of 0.00 indicating that Sight Sciences is being referred to more favorably in the media.
Sight Sciences has a net margin of -63.30% compared to CollPlant Biotechnologies' net margin of -2,680.00%. Sight Sciences' return on equity of -47.28% beat CollPlant Biotechnologies' return on equity.
Sight Sciences presently has a consensus target price of $4.68, indicating a potential upside of 85.11%. CollPlant Biotechnologies has a consensus target price of $12.50, indicating a potential upside of 260.23%. Given CollPlant Biotechnologies' stronger consensus rating and higher probable upside, analysts plainly believe CollPlant Biotechnologies is more favorable than Sight Sciences.
Sight Sciences has a beta of 2.52, indicating that its stock price is 152% more volatile than the S&P 500. Comparatively, CollPlant Biotechnologies has a beta of 0.86, indicating that its stock price is 14% less volatile than the S&P 500.
CollPlant Biotechnologies received 121 more outperform votes than Sight Sciences when rated by MarketBeat users. Likewise, 59.83% of users gave CollPlant Biotechnologies an outperform vote while only 31.15% of users gave Sight Sciences an outperform vote.
CollPlant Biotechnologies has lower revenue, but higher earnings than Sight Sciences. Sight Sciences is trading at a lower price-to-earnings ratio than CollPlant Biotechnologies, indicating that it is currently the more affordable of the two stocks.
Summary
Sight Sciences beats CollPlant Biotechnologies on 10 of the 18 factors compared between the two stocks.
Get CollPlant Biotechnologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for CLGN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
CollPlant Biotechnologies Competitors List
Related Companies and Tools
This page (NASDAQ:CLGN) was last updated on 2/22/2025 by MarketBeat.com Staff
